Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Aug;69(8):4870-3.
doi: 10.1128/IAI.69.8.4870-4873.2001.

Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci

R Malley  1 , M Lipsitch, A Stack, R Saladino, G Fleisher, S Pelton, C Thompson, D Briles, P Anderson
Affiliations

Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci

R Malley et al. Infect Immun. 2001 Aug.

Abstract

A whole-cell killed unencapsulated pneumococcal vaccine given by the intranasal route with cholera toxin as an adjuvant was tested in two animal models. This vaccination was highly effective in preventing nasopharyngeal colonization with an encapsulated serotype 6B strain in mice and also conferred protection against illness and death in rats inoculated intrathoracically with a highly encapsulated serotype 3 strain. When the serotype 3 challenge strain was incubated in the sera of immunized rats, it was no longer virulent in an infant-rat sepsis model, indicating that the intranasal immunization elicited protective systemic antibodies. These studies suggest that killed whole-cell unencapsulated pneumococci given intranasally with an adjuvant may provide multitypic protection against capsulated pneumococci.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Berry A M, Lock R A, Hansman D, Paton J C. Contribution of autolysin to virulence of Streptococcus pneumoniae. Infect Immun. 1989;57:2324–2330. - PMC - PubMed
    1. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187–195. - PubMed
    1. Boyce T G, Hsu H H, Sannella E C, Coleman-Dockery S D, Baylis E, Zhu Y, Barchfeld G, DiFrancesco A, Paranandi M, Culley B, Neuzil K M, Wright P F. Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. Vaccine. 2000;19:217–226. - PubMed
    1. Briles D E, Nahm M, Schroer K, Davie J, Baker P, Kearney J, Barletta R. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med. 1981;153:694–705. - PMC - PubMed
    1. Briles D E, King J D, Gray M A, McDaniel L S, Swiatlo E, Benton K A. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine. 1996;14:858–867. - PubMed

Publication types

MeSH terms